Education
About Us
Working with TipRanks
Follow Us
Theravance Biopharma (TBPH)
NASDAQ:TBPH
Earnings Data
Report Date
Mar 02, 2026Before Open (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
1Last Year’s EPS
-0.31Same Quarter Last Year
Strong Buy
Based on 6 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call reflects a strong financial position with record sales and profitability for YUPELRI, significant progress in ampreloxetine's clinical trials, and upcoming milestone achievements for Trelegy. Despite minor operational challenges, the overall outlook remains positive with a focus on future growth and strategic objectives.Company Guidance
YUPELRI Sales Growth
Third quarter net sales for YUPELRI increased 15% year over year to $71.4 million, driven by a 6% increase in demand and favorable net pricing.
Record Profitability and Financial Strength
Theravance achieved non-GAAP breakeven and ended the quarter with $333 million in cash and no debt. The company is on track to achieve near-term milestones totaling $75 million in the fourth quarter.
Trelegy Milestone Achievements
Trelegy sales reached $1 billion for the quarter, setting up the achievement of a $50 million milestone in 2025 and a $100 million milestone in 2026.
Ampreloxetine Phase III Progress
The pivotal Phase III Cyprus trial for ampreloxetine is on track for data readout in early 2026, with significant progress in NDA preparation. A KOL event for investors is planned to highlight its potential.
TBPH Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
TBPH Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 10, 2025 | $15.08 | $18.50 | +22.68% |
Aug 12, 2025 | $11.92 | $12.42 | +4.19% |
May 08, 2025 | $9.90 | $8.98 | -9.29% |
Feb 26, 2025 | $9.08 | $9.27 | +2.09% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Theravance Biopharma (TBPH) report earnings?
Theravance Biopharma (TBPH) is schdueled to report earning on Mar 02, 2026, Before Open (Confirmed).
What is Theravance Biopharma (TBPH) earnings time?
Theravance Biopharma (TBPH) earnings time is at Mar 02, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is TBPH EPS forecast?
TBPH EPS forecast for the fiscal quarter 2025 (Q4) is 1.